| Literature DB >> 24728623 |
M Nussbaumer1, L Donath, M Fischer, J Schäfer, O Faude, L Zahner, A Schmidt-Trucksäss, H Hanssen.
Abstract
Alterations of retinal vessel diameters are associated with increased cardiovascular risk. We aimed to investigate changes in retinal vessel diameters in response to acute dynamic exercise of different intensities and whether these changes are age dependent. Seventeen healthy seniors (median (IQR) age 68 (65, 69) years) and 15 healthy young adults (median (IQR) age 26 (25, 28) years) first performed a maximal treadmill test (MTT) followed by a submaximal treadmill test (SMTT) and a resting control condition in randomised order. Central retinal arteriolar (CRAE) and central retinal venular (CRVE) diameter equivalents were measured before as well as 5 (t5) and 40 (t40) minutes after exercise cessation using a static retinal vessel analyser. Both exercise intensities induced a significant dilatation in CRAE and CRVE at t5 compared to the control condition (P < 0.001). At t40, the mean increase in CRAE and CRVE was greater for MTT compared to that for SMTT (CRAE 1.7 μm (95 % confidence interval (CI) -0.1, 3.6; P = 0.061); CRVE 2.2 μm (95 % CI 0.4, 4.1; P = 0.019)). However, the estimated difference at t5 between seniors and young adults in their response to MTT compared to SMTT was 5.3 μm (95 % CI 2.0, 8.5; P = 0.002) for CRAE and 4.1 μm (95 % CI -0.4, 8.6; P = 0.076) for CRVE. Wider arteries and veins after maximal versus submaximal exercise for seniors compared to young adults suggest that myogenic vasoconstriction in response to exhaustive exercise may be reduced in seniors. Age-related loss of vascular reactivity has clinical implications since the arteriolar vasoconstriction protects the retinal capillary bed from intraluminal pressure peaks.Entities:
Mesh:
Year: 2014 PMID: 24728623 PMCID: PMC4082577 DOI: 10.1007/s11357-014-9650-3
Source DB: PubMed Journal: Age (Dordr) ISSN: 0161-9152
Fig. 1Participants were examined in a cross-over design. At the first visit, all study participants performed a maximal treadmill test (MTT). At the second and third visits, participants performed a submaximal 2-km treadmill test () and a control condition (CC) in randomised order. Central retinal arteriolar (CRAE (in micrometre)) and venular (CRVE (in micrometre)) equivalents were measured before and after exercise cessation using a static retinal vessel analyser (SVA)
Participant characteristics with continuous data summarised as median (interquartile range) and categorical data as n (%)
| Characteristic | All participants ( | Seniors ( | Young adults ( |
|---|---|---|---|
| Age, years | 68 (65, 69) | 26 (25, 28) | |
| Female gender | 19 (59) | 12 (71) | 7 (47) |
| Height, cm | 168 (164, 178) | 167 (163, 170) | 175 (167, 181) |
| Weight, kg | 66 (58, 76) | 66 (62, 75) | 67 (57, 77) |
| BMI, kg/m2 | 23 (22, 25) | 24 (22, 26) | 22 (19, 23) |
| Baseline SBPa, mmHg | 124 (115, 137) | 133 (124, 139) | 115 (108, 124) |
| Baseline DBPa, mmHg | 80 (74, 88) | 85 (80, 88) | 78 (73, 81) |
| Baseline AVR | 0.87 (0.83, 0.9) | 0.87 (0.83, 0.91) | 0.87 (0.84, 0.9) |
| Baseline CRAE, in μm | 188 (177, 194) | 188 (176, 194) | 190 (180, 194) |
| Baseline CRVE, in μm | 216 (203, 229) | 209 (203, 234) | 224 (210, 228) |
Baseline measurements are those taken at the first visit before the start of maximal exercise testing
BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, AVR arteriolar-to venular diameter ratio, CRAE central retinal arteriolar equivalent, CRVE central retinal venular equivalent
aAvailable in 14 (82 %) and 15 (100 %) seniors and young adults, respectively
Exercise performance and control condition with data summarised as median (interquartile range)
| Performance measure | All participants ( | Seniors ( | Young adults ( |
|---|---|---|---|
| Maximum treadmill test (MTT) | |||
| Relative VO2peak a, mL/min/kg | 38 (31, 51) | 31 (25, 34) | 52 (45, 56) |
| HRmax b, bpm | 172 (160, 192) | 160 (157, 167) | 193 (184, 195) |
| RERa | 1.16 (1.09, 1.21) | 1.1 (1.03, 1.18) | 1.18 (1.14, 1.21) |
| PetCO2 d, mmHg | 34.0 (32.2, 37.6) | 33.2 (31.1 , 34.4) | 36.3 (33.2, 39.0) |
| PaCO2 d, mmHg | 36.1 (34.5, 39.3) | 35.3 (33.5, 36.5) | 38.2 (35.4, 40.6) |
| V’Ed, L/min | 91 (67, 136) | 57 (56, 90) | 129 (84, 149) |
| VTd, L | 2.2 (1.8, 2.8) | 1.6 (1.5, 2.3) | 2.6 (2.0, 3.4) |
| Submaximal 2-km treadmill test (SMTT) | |||
| Relative VO2, mL/min/kg | 26 (19, 30) | 19 (17, 23) | 30 (28, 32) |
| HR, bpm | 127 (122, 143) | 122 (112, 126) | 142 (135, 162) |
| RER | 0.93 (0.88, 1.0) | 0.89 (0.82, 0.94) | 0.97 (0.93, 1.01) |
| PetCO2 d, mmHg | 37.1 (36.1, 40.1) | 36.5 (34.4, 37.0) | 39.0 (36.7, 41.7) |
| PaCO2 d, mmHg | 38.9 (38.0, 41.6) | 38.4 (36.4, 38.8) | 40.6 (38.6, 43.1) |
| V’Ed, L/min | 48 (39, 57) | 33 (30, 39) | 55 (48, 60) |
| VTd, L | 1.7 (1.3, 1.9) | 1.2 (1.1, 1.6) | 1.9 (1.5, 2.2) |
| Control condition (CC) | |||
| Relative VO2 c, mL/min/kg | 3.5 (3, 4) | 3 (2.8, 4) | 3.6 (3.5, 4) |
| HRd, bpm | 56 (54, 65) | 64 (53, 68) | 55 (54, 59) |
| RERc | 0.86 (0.82, 0.9) | 0.83 (0.82, 0.9) | 0.87 (0.85, 0.9) |
| PetCO2 d, mmHg | 36.2 (32.8, 38.0) | 34.3 (31.5, 36.4) | 36.8 (34.7, 39.0) |
| PaCO2 d, mmHg | 38.1 (35.1, 39.7) | 36.4 (33.9, 38.3) | 38.6 ( 36.7, 40.6) |
| V’Ed, L/min | 8 (6, 9) | 7 (6, 8) | 8 (8, 9) |
| VTd, L | 0.5 (0.4, 0.6) | 0.5 (0.4, 0.5) | 0.6 (0.5, 0.7) |
VO peak oxygen consumption, VO oxygen consumption, HR maximum heart rate, HR heart rate, bpm beats per minute, RER respiratory exchange ratio, PetCO partial pressure of end-tidal carbon dioxide, PaCO estimated arterial partial pressure of carbon dioxide, V’E minute ventilation/respiratory minute volume, VT tidal volume
aAvailable in 15 (88 %) and 15 (100 %) seniors and young adults, respectively
bAvailable in 17 (100 %) and 14 (93 %) seniors and young adults, respectively
cAvailable in 16 (94 %) and 15 (100 %) seniors and young adults, respectively
dAvailable in 8 (47 %) and 15 (100 %) seniors and young adults, respectively
Fig. 2Retinal vessel diameters at baseline as well as 5 min (t 5) and 40 min (t 40) after a maximal treadmill test (MTT), a submaximal 2-km treadmill test (SMTT) and a resting control condition (CC). a Central retinal arteriolar equivalent (CRAE (in micrometre)). b Central retinal venular equivalent (CRVE (in micrometre))
Estimated baseline-adjusted exercise mode effects on mean central retinal arteriolar equivalent (CRAE) and on mean central retinal venular equivalent (CRVE)
| Estimate (95 % CI) |
| ||
|---|---|---|---|
| CRAE, μm | |||
| t5 exercise mode effects | SMTT–CC | 4.9 (3.1, 6.7) | <0.001 |
| MTT–CC | 3.7 (1.9, 5.5) | <0.001 | |
| MTT–SMTT | −1.2 (−3.0, 0.7) | 0.206 | |
| t40 exercise mode effects | SMTT–CC | 3.3 (1.5, 5.2) | <0.001 |
| MTT–CC | 5.1 (3.2, 6.9) | <0.001 | |
| MTT–SMTT | 1.7 (−0.1, 3.6) | 0.061 | |
| CRVE, μm | |||
| t5 exercise mode effects | SMTT–CC | 6.3 (4.4, 8.1) | <0.001 |
| MTT–CC | 5.1 (3.3, 7.0) | <0.001 | |
| MTT–SMTT | −1.1 (−3.0, 0.7) | 0.224 | |
| t40 exercise mode effects | SMTT–CC | 3.7 (1.8, 5.5) | <0.001 |
| MTT–CC | 5.9 (4.0, 7.7) | <0.001 | |
| MTT–SMTT | 2.2 (0.4, 4.1) | 0.019 | |
CI confidence interval, CRAE central retinal arteriolar equivalent, CRVE central retinal venular equivalent, MTT maximal treadmill test, SMTT submaximal treadmill test, CC control condition
Fig. 3Differences in retinal vessel diameter between maximal treadmill test (MTT), submaximal 2-km treadmill test (SMTT) and resting control condition (CC) for seniors and for young adults. a Difference in central retinal arteriolar equivalent (CRAE (in micrometre)) between SMTT and CC for seniors and for young adults. b Difference in CRAE between MTT and CC for seniors and for young adults. c Difference in CRAE between MTT and SMTT for seniors and for young adults. d Difference in central retinal venular equivalent (CRVE (in micrometre)) between SMTT and CC for seniors and for young adults. e Difference in CRVE between MTT and CC for seniors and for young adults. f Difference in CRVE between MTT and SMTT for seniors and for young adults
Estimated baseline-adjusted age-group effects (comparing seniors with young adults) on mean difference in central retinal arteriolar equivalent (CRAE) and central retinal venular equivalent (CRVE) between each two exercise modes
| Estimate (95 % CI) |
| ||
|---|---|---|---|
| CRAE, μm | |||
| t5 difference in exercise response between seniors and young adults | SMTT–CC | −2.4 (−6.2, 1.3) | 0.190 |
| MTT–CC | 2.9 (−0.5, 6.3) | 0.088 | |
| MTT–SMTT | 5.3 (2.0, 8.5) | 0.002 | |
| t40 difference in exercise response between seniors and young adults | SMTT–CCa | −1.7 (−6.1, 2.7) | 0.439 |
| MTT–CCa | 0.3 (−4.2, 4.9) | 0.878 | |
| MTT–SMTT | 1.4 (−2.3, 5.1) | 0.438 | |
| CRVE, μm | |||
| t5 difference in exercise response between seniors and young | SMTT–CC | 0.4 (−4.1, 5.0) | 0.848 |
| MTT–CC | 5.0 (1.5, 8.4) | 0.006 | |
| MTT–SMTT | 4.1 (−0.4, 8.6) | 0.076 | |
| t40 difference in exercise response between seniors and young | SMTT–CCa | 1.0 (−2.7, 4.8) | 0.572 |
| MTT–CCa | 1.7 (−2.3, 5.6) | 0.401 | |
| MTT–SMTT | 0.4 (−3.5, 4.2) | 0.844 | |
CI confidence interval, CRAE central retinal arteriolar equivalent, CRVE central retinal venular equivalent, MTT maximal treadmill test, SMTT submaximal treadmill test, CC control condition.
aAvailable in 16 (94 %) and 15 (100 %) seniors and young adults, respectively